Radionuclide targeting of bone metastases: which efficacy?
Leyvraz
S
S
Burckhardt
P
P
D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy; D001918:Brachytherapy / Q000379:methods; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D000077268:Pamidronate; D011868:Radioisotopes / Q000627:therapeutic use*; D012493:Samarium / Q000627:therapeutic use*
D004164:Diphosphonates; D009943:Organophosphorus Compounds; D011868:Radioisotopes; C018940:(ethylenedinitrilo)-tetramethylenephosphonic acid; D012493:Samarium; D000077268:Pamidronate